Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TERF1 interacting nuclear factor 2 | 0.575 | 0.731 | 1.3E-03 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
complement C1s | 0.705 | 0.462 | 6.8E-04 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
dedicator of cytokinesis 8 | 0.578 | 0.731 | 1.5E-11 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
transmembrane protein 94 | 0.628 | 0.654 | 2.8E-14 |
|
group | 0.100 | None | 0 | 2 | |||||||||||
|
deoxyribonuclease 1 like 3 | 0.575 | 0.769 | 3.0E-05 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1971 | 1971 | ||||||||
|
calcitonin related polypeptide alpha | 0.416 | 0.923 | 1.6E-02 |
|
group | 0.100 | None | 0.921 | 89 | 0 | 1975 | 2019 | ||||||||
|
CEA cell adhesion molecule 5 | 0.420 | 0.846 | 4.2E-10 |
|
group | 0.100 | None | 0.956 | 502 | 0 | 1976 | 2020 | ||||||||
|
alpha fetoprotein | 0.429 | 0.885 | 1.1E-11 |
|
group | 0.100 | None | 0.960 | 428 | 3 | 1977 | 2020 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
group | 0.100 | None | 0.952 | 167 | 0 | 1977 | 2020 | ||||||||
|
plasminogen | 0.389 | 0.923 | 1.0E-02 |
|
group | 0.100 | None | 0.973 | 75 | 0 | 1977 | 2019 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
group | 0.100 | None | 0.982 | 169 | 0 | 1978 | 2020 | ||||||||
|
dopamine beta-hydroxylase | 0.511 | 0.846 | 3.3E-10 |
|
group | 0.040 | None | 0.750 | 4 | 0 | 1978 | 2019 | ||||||||
|
gastrin | 0.485 | 0.808 | 2.7E-03 |
|
group | 0.100 | None | 0.959 | 74 | 0 | 1979 | 2020 | ||||||||
|
vasoactive intestinal peptide | 0.437 | 0.846 | 4.2E-04 |
|
group | 0.100 | None | 1.000 | 31 | 0 | 1979 | 2019 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
group | 0.200 | None | 1.000 | 43 | 0 | 1980 | 2019 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
group | 0.100 | None | 0.943 | 1380 | 16 | 1981 | 2020 | ||||||||
|
dihydrolipoamide dehydrogenase | 0.517 | 0.769 | 9.5E-03 |
|
group | 0.100 | None | 0.958 | 24 | 1 | 1981 | 2019 | ||||||||
|
arylsulfatase A | 0.448 | 0.923 | 1.1E-11 |
|
group | 0.100 | None | 1.000 | 20 | 0 | 1981 | 2020 | ||||||||
|
pancreatic polypeptide | 0.663 | 0.308 | 1.2E-02 |
|
group | 0.090 | None | 1.000 | 9 | 0 | 1981 | 2002 | ||||||||
|
immunoglobulin heavy locus | 0.473 | 0.654 |
|
group | 0.100 | None | 0.979 | 48 | 0 | 1982 | 2020 | |||||||||
|
plasminogen activator, tissue type | 0.445 | 0.885 | 5.7E-05 |
|
group | 0.100 | None | 1.000 | 45 | 0 | 1982 | 2019 | ||||||||
|
heparan sulfate proteoglycan 2 | 0.438 | 0.885 | 1.0E-19 |
|
group | 0.100 | None | 0.971 | 35 | 0 | 1982 | 2019 | ||||||||
|
Alzheimer disease 12 | 0.711 | 0.538 |
|
group | 0.100 | None | 0.923 | 13 | 0 | 1982 | 2009 | |||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.400 | None | 0.953 | 1448 | 13 | 1983 | 2020 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
group | 0.500 | None | 0.967 | 631 | 7 | 1983 | 2020 |